Try our beta test site

Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) (COAPT)

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2017 by Evalve
Sponsor:
Collaborator:
Abbott Vascular
Information provided by (Responsible Party):
Evalve
ClinicalTrials.gov Identifier:
NCT01626079
First received: June 20, 2012
Last updated: January 31, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2021
  Estimated Primary Completion Date: July 2018 (Final data collection date for primary outcome measure)